Results 291 to 300 of about 355,585 (385)

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

A narrative literature review on the clinical utility of activated partial thromboplastin time and anti-factor Xa activity assays in cancer patients with anticoagulant therapy. [PDF]

Transl Cancer Res
Li HX, Song LH, Chen YH, Zhao J, Zhang XF.   +4 more
europepmc   +1 more source

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.

Europace, 2013
H. Heidbuchel, P. Verhamme, M. Alings, M. Antz, W. Hacke, J. Oldgren, P. Sinnaeve, A. Camm, P. Kirchhof, P. Kirchhof   +9 more
semanticscholar   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Analysis of hemorrhagic transformation and intracerebral hemorrhage under combination therapy with alteplase and antiplatelets or anticoagulants, using the Japanese Adverse Drug Event Report database. [PDF]

PLoS One
Nakai T, Koseki T, Nakao H, Kato K, Takahashi K, Yamada S, Matsumoto S.   +6 more
europepmc   +1 more source

Anticoagulant versus antiplatelet treatment for secondary stroke prevention in patients with active cancer [PDF]

Moritz Kielkopf, Jayan Göcmen, Selina B. Venzin, Fabienne Steinauer, Mattia Branca, Anna Boronylo, Martina Göldlin, Johannes Kaesmacher, Adnan Mujanović, Gianluca Costamagna, Thomas R. Meinel, David Seiffge, Philipp Bücke, Mirjam R. Heldner, Ava L. Liberman, Hooman Kamel, Urs Fischer, Marcel Arnold, Thomas Pabst, Martin D. Berger, Simon Jung, Adrian Scutelnic, Babak B. Navi, Morin Beyeler   +23 more
openalex   +1 more source

Direct Oral Anticoagulants: A Quick Guide.

European Cardiology, 2017
Sikorska Julia, Uprichard James
semanticscholar   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Clinical outcomes in elderly patients on direct oral anticoagulant drugs undergoing surgery for acute hip fracture (AHF). [PDF]

Eur J Trauma Emerg Surg
Wemmert E, Eklöf P, Linder V, Rydberg EM, Dalla K, Nellgård B, Hessulf F, Piasecki A.   +7 more
europepmc   +1 more source

Design, Synthesis, and Biological Evaluation of Peptidomimetic Inhibitors of Factor XIa as Novel Anticoagulants

, 2006
Jian Lin, Hongfeng Deng, Lei Jin, Pramod S. Pandey, Jesse Quinn, Susan Cantin, Michael J. Rynkiewicz, Joan C. Gorga, F. Bibbins, Cassandra A. Celatka, Pamela Nagafuji, Thomas D. Bannister, Harold V. Meyers, Robert E. Babine, Neil J. Hayward, David T. Weaver, Howard W. Benjamin, F L Stassen, Sherin S. Abdel‐Meguid, James E. Strickler   +19 more
openalex   +1 more source